Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Will Firefly’s $855M SciTec Acquisition Ignite a Stock Re-Rating?

Firefly's acquisition of SciTec is a strategic pivot to reshape its valuation by blending space hardware with high-margin defense intelligence.

MarketBeat

Lithium Americas: Why This 31% Rally Is More Than Just a Headline

Lithium Americas' partnership with the U.S. government solidifies its path to production and positions it as a key player in the domestic EV supply chain.

MarketBeat

Why Archer Aviation Stock Is Soaring—And What Comes Next

Archer Aviation's rally is fueled by tangible progress, including a public flight debut and key partnerships, attracting bullish options and retail interest.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Why AbbVie and Johnson & Johnson Could Outperform Pfizer

Pfizer stock is moving higher after being named part of the TrumpRx platform; but two other biopharma companies may offer better long-term growth potential

MarketBeat

EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector

With EA likely going private in a $55-billion deal, opportunities may arise for other gaming companies. Here are some considerations for investors.

MarketBeat

These Are the 3 Hottest Sectors for Q3 Earnings Growth

The forecasts for Q3 earnings are on the rise, suggesting a strong reporting cycle. This is an examination of the top sectors for growth and outperformance

MarketBeat

AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal

Advanced Micro Devices is on track to double in share price, reaching the $400 level in mid-2026 as expectations for MI450 sales intensify.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

The Juice Is Loose: Why Plug Power's Rally Is Just the Beginning

Plug Power's stock surge is backed by landmark gigawatt-scale electrolyzer deals and a new growth story tied to the power demands of the AI industry.

MarketBeat

These 2 Must-Watch Firms Could Get a Boost From Earnings Reports

Two companies reporting earnings in early October could be winners for the upcoming earnings season, based on strong forecasts and notable recent achievements.

MarketBeat

3 Dividend Aristocrats to Buy Before Year’s End

Dividend Aristocrats offer attractive entries at long-term lows: the dividends are reliable, and the share prices are likely to recover.

MarketBeat

Why Semtech Stock Is Rallying After Its NVIDIA Setback

After its NVIDIA-induced cratering, Semtech is up more than 80%. Analysts see more upside to come in this surging chip stock.

MarketBeat

SharkNinja Is Flashing a Buy Signal the Market Is Ignoring

SharkNinja's recent stock decline overlooks its strong earnings, innovation, and significant international growth, creating a clear market disconnect.

MarketBeat

When Downgrades Create Opportunities: 3 Stocks to Watch Now

Analyst downgrades serve as catalysts for buying opportunities in high-quality stocks like Salesforce and Accenture, well-positioned for AI and automation.

MarketBeat

3 REITs to Watch as Rate Cuts Ignite a Real Estate Super Cycle

REITs are standing on several tailwinds now created by recent Fed cuts into high inflation and high asset prices, where property values could rise higher.

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

2 Defense Stocks Riding 2025’s Massive Momentum Wave

KTOS and KRMN are two momentum defense stocks with astounding returns in 2025. However, with their forward P/E ratios nearing 150x, warning signs are flashing.

MarketBeat

TrumpRx Brings Pfizer Into the Green—Is It a Buy?

Pfizer entered into a major agreement with the U.S. government to produce more affordable drugs for Americans. However, the stock’s outlook is still cloudy.

MarketBeat

Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal

Eli Lilly just got great news, courtesy of Pfizer and Trump, leading shares to their highest level in five months. Its rally may just be getting started.

MarketBeat

3 Exceptional Stocks to Build Long-Term Wealth

Discover three standout growth stocks with strong long-term potential, spanning space, retail, and biotech industries, poised for sustained investor returns

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?

CoreWeave and Broadcom are bringing in big returns for investors in 2025. However, with insider selling surging, should the future of these names be a concern?

MarketBeat

Marvell Insiders Buy Shares—Should Investors Follow Suit?

Marvell Technology insiders purchased stock after the company announced a buyback plan, affirming a robust outlook for the company's business strength.

MarketBeat

Trump’s Drug Price Cuts: Boom or Bust for These 3 Pharma Giants

Trump’s drug price plan drove a Pfizer rally, leaves Eli Lilly buffered by U.S. investments, and could boost JNJ if it secures similar tariff relief.

MarketBeat

3 Fintech Stocks That Are Set to Rise as Rates Fall

Fed rate cuts may unlock upside for UPST, AFRM, and RKT stocks, boosting loan volumes, BNPL demand, and mortgage refinancing.

MarketBeat

Cleveland-Cliffs Rally Tops S&P 500, Can It Continue?

Cleveland-Cliffs stock is outperforming the S&P 500 by a wide margin this month, driven by several fundamental tailwinds that are set to continue further.

MarketBeat

Joby's Stock Rallies as Public Flights Validate Global Game Plan

Joby Aviation's global flight demonstrations in Japan and the US provide tangible proof of its operational maturity, justifying renewed investor confidence.

MarketBeat

3 Travel Stocks to Watch Heading Into the Holidays

Travel and entertainment spending is expected to increase this holiday season; here are three travel stocks offering opportunities for investors

1 … 74 75 76 77

People

Donald Trump

180,747 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Advanced Micro Devices

431 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.